Phase II trial of treatment based on gene profiling diagnosis using next generation sequencing for carcinoma of unknown primary site
Phase 2
- Conditions
- ntreated Carcinoma of Unknown Primary Site
- Registration Number
- JPRN-UMIN000016794
- Lead Sponsor
- Ministry of Health, Labour and Welfare scientific research Nakagawa squad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients with the specific sub groups are not eligible: (2)Patients with uncontrolled brain metastases and all patients with meningeal metastases. (3)Women who are pregnant or lactating. drug within 28 days of starting treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method One year overall survival rate
- Secondary Outcome Measures
Name Time Method Overall survival, Progression free survival, response rate, safety, exploratory anarysis association between results of gene profiling and efficacy, Frequency of gene mutation/amplification